OraSure Technologies | OSUR - Ebitda


OraSure Technologies reported $-17.7M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Agilent USD 577M 77M Jun/2026
AngioDynamics USD 5.94M 3.78M Sep/2025
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Bio Techne USD 115.94M 763K Jun/2026
Bio-Rad Laboratories USD 119.9M 475.4M Sep/2026
Bruker USD 143.2M 33.2M Jun/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Danaher USD 2.1B 257M Sep/2026
Dentsply International USD 146M 44M Sep/2026
Dexcom USD 435.2M 46.5M Sep/2026
Illumina USD 330M 80M Jun/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Mettler Toledo International USD 366.1M 43.45M Sep/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 148M 18.7M Sep/2026
Repligen USD 43.84M 70K Sep/2026
Revvity USD 227.55M 629K Sep/2026
STAAR Surgical USD 14.36M 5.64M Sep/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Trinity Biotech USD -9.6M 7.64M Dec/2024
Waters USD 554M 158M Sep/2026